SCHEMBL372610

SCHEMBL372610

CCOC(=O)[C@@H](C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196408 1.00
SCHEMBL135308 1.00
Hydrochloric Acid SCHEMBL842523 0.97
Water SCHEMBL28328236 0.97
Hydrochloric Acid SCHEMBL135306 0.97
Bromide SCHEMBL5401279 0.97
Bromide SCHEMBL5401276 0.97
Hydrochloric Acid SCHEMBL135307 0.97
Hydrochloric Acid SCHEMBL5202071 0.95
Hydrochloric Acid SCHEMBL2255171 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103897181-B Polymer, and preparation method and application thereof 张昊 2017-02-08 CN claimed
CN-103897196-B Polymer and preparation method thereof 张昊 2016-12-28 CN claimed
CN-106045986-A Novel phenothiazine derivative and preparation method and application thereof 广东工业大学 2016-10-26 CN claimed
CN-106008494-A 4-oxo-2-thiothiazolidine containing derivative, preparation method and application thereof 广东工业大学 2016-10-12 CN claimed
CN-103897196-A Polymer and preparation method thereof ZHANG HAO 2014-07-02 CN claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
EP-0857790-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS KANEKA CORP (JP) 2005-08-17 EP claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
US-20010031487-A1 Process for producing optically active amino compounds KANEKA CORPORATION 2001-10-18 US claimed
EP-0857790-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS KANEKA CORPORATION (JP) 1998-08-12 EP claimed
EP-0796245-A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE $g(b)-ALANINE UREA ANALOGS G.D. SEARLE &amp; CO. (US) 1997-09-24 EP claimed
WO-2026103907-A1 THYROID HORMONE RECEPTOR β AGONIST 上海柯君医药科技有限公司 2026-05-21 WO disclosed
US-12601929-B2 Contact lens COOPERVISION INTERNATIONAL LIMITED (GB) 2026-04-14 US disclosed
EP-3700578-B1 SYSTEMS FOR RENAL FUNCTION DETERMINATION MEDIBEACON INC (US) 2025-12-03 EP disclosed
US-20250295679-A1 Compositions and Dosage Forms for Treatment of HPV Infection and HPV-Induced Neoplasia ANTIVA BIOSCIENCES, INC. (US) 2025-09-25 US disclosed
US-4654355-A 7-oxabicycloheptane substituted amide-thioamide prostaglandin analogs E. R. SQUIBB & SONS, INC. (US) 1987-03-31 US disclosed
EP-0022634-B1 ACYLATED INDOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS AND DRUGS COMPRISING THEM TEIJIN LIMITED (JP) 1983-04-06 EP disclosed
US-4272432-A Claudogenic-interceptive nonapeptide AMERICAN HOME PRODUCTS CORPORATION (US) 1981-06-09 US disclosed
US-4256748-A INOTROPIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1981-03-17 US disclosed
EP-0022634-A1 Acylated indole derivatives, processes for their preparation and pharmaceutical compositions and drugs comprising them TEIJIN LIMITED (JP) 1981-01-21 EP disclosed